The Moran Eye Center doctor talks emerging research on eye pressure and glaucoma, and where GLP-1 medications fit into protecting vision.
Recap by typeshit. Post by Moran Eye Center on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
The obesity doctor argues the oral Wegovy pill could bring new patients into treatment rather than just pulling users away from injectable GLP-1s.
Forbes covers peptide use in pets. Only the headline is available, so tap through for the details.
Loading…